Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Corsair Gaming Inc (CRSR) vs Revvity Inc (RVTY) Price & Performance

Corsair Gaming IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Corsair Gaming Inc vs Revvity Inc — how do they compare? Corsair Gaming Inc trades at $9.24 (market cap $1.03B), while Revvity Inc trades at $111.18 (market cap $12.41B). The key difference: Revvity Inc is far larger — about 12× Corsair Gaming Inc's market cap, and Revvity Inc pays a 0.25% dividend while Corsair Gaming Inc pays none. Which is the better fit depends on your goals.

CRSRRVTY
Market Cap
$1.03B$12.41B
Sector
TechnologyTechnology
52-Week High
$12.14$117.75
52-Week Low
$4.58$82.26
Enterprise Value
$1.10B$14.90B
Dividend Yield
0.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Corsair Gaming Inc

CRSR trades at $9.47, down 1.97% today, with a bullish technical signal from moving averages and a consensus analyst price target of $9.00. Recent earnings beat expectations in Q4 2025 and Q1 2026, though Q3 2025 missed. Revenue for 2025 was $1.47B with a net loss of $16.16M, but 2026 projects a net profit of $7M. Positive news includes AI product launches and partnerships, driving investor optimism amid a mixed analyst rating of 4 Buy and 7 Hold.

Outlook is cautiously optimistic with potential from AI expansion and earnings growth, but risks include thin profit margins and competitive pressures. The stock's current price near the consensus target suggests limited upside, requiring strong execution for further gains. Investors should weigh the bullish technicals against fundamental challenges in the gaming hardware sector.

Revvity Inc

RVTY trades at $111.11, down 1.05% today, with a bullish technical signal from moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.06 exceeding expectations. Recent developments include AI integration with Anthropic's Claude and FDA clearance for a testosterone assay, signaling innovation in diagnostics and life sciences.

The outlook remains positive with strong analyst support (51.72% buy ratings) and a consensus price target of $111.43. Key risks include margin pressure from China divestment plans and weak academic demand. Revenue stability around $2.9B supports valuation, though high P/E of 53.47 requires sustained growth to justify.

Returns comparison

Trailing returns across standard periods

About Corsair Gaming Inc

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment

Read more on CRSR

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY